BioNTech SE (BNTX) has released an update.
BioNTech SE is currently embroiled in a legal battle with the University of Pennsylvania over alleged unpaid royalties on its COVID-19 vaccine sales. The lawsuit was filed by the University on August 5, 2024, in the U.S. District Court for the Eastern District of Pennsylvania. BioNTech has expressed its intention to robustly defend against the allegations presented in the complaint.
For further insights into BNTX stock, check out TipRanks’ Stock Analysis page.
